For a startup biotech running its first Phase 2, a 6-month enrollment delay is not just expensive — it can end the program. Hekma gives you enterprise-grade patient recruitment and trial execution without the enterprise price tag or implementation timeline.
1,842
Patients Identified
612
Pre-Screened
47
Enrolled
17
Days to First Patient
CTMS live in: 3 business days
Who This Page Is For
Under 500 employees with active Phase 1, 2, or 3 trials in oncology, cardiology, CNS, or rare disease. Companies with limited in-house clinical operations capacity that need a platform that deploys fast and produces results faster.
The Reality of Your Situation
You have investors watching your milestones. Your lead compound is in the clinic. Your CRO has committed to an enrollment timeline. Small and mid-sized biotechs have been running trials the same way large pharma runs trials — with tools built for large pharma budgets and large pharma teams. That's why 50%+ of biotech trials miss their enrollment targets.
What You Get With Hekma
Run your I/E criteria against our network before you commit to enrollment timelines
Eligibility-scored candidates arrive at your sites. Coordinators enroll, not screen.
Protocol sync, site coordination, adverse event tracking — no 12-month implementation
Care calendars, automated reminders, dropout prevention — from day one of enrollment
Pay for what you use. No long-term commitment required for your first trial.
No $250K minimum. No 6-month vendor evaluation. Start in days, not quarters.
Start with patient recruitment only. Add CTMS when you need it. Add engagement module at enrollment. You build as you grow.
Protocol to first patient delivered in under 3 weeks. CTMS live in 3–5 days for SaaS. No consultant required to operate.
Real-time enrollment dashboard shows investors exactly where the trial is. No more 'we're waiting on sites' updates.
Compliance & Standards
Enterprise-grade recruitment and trial execution. Per-trial pricing. Deployed in days.